Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03452878 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study completion date: Dec 31, 2025 to Dec 31, 2026v5
  2. Minor Study completion date: Dec 31, 2023 to Dec 31, 2025v4
  3. Minor Study completion date: Dec 31, 2020 to Dec 31, 2023v3
  4. Minor Study completion date: Dec 31, 2018 to Dec 31, 2020v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aggressiveness has a high prevalence in the psychiatry population and is of major concern. Though pharmacological treatments are effective for most patients, there is a portion that doesn't respond properly and is considered medically refractory. For them, surgical procedures (i.e. stereotactic lesions) have been performed as an attempt to reintegrate patient into society. The amygdala is a main structure in the control of aggressive behavior and amygdala lesion could improve behavior without neurological or other behavioral impairment. In this study, it will evaluate the functional results of the bilateral amygdala lesion of aggressive refractory patients through neuroimaging, clinical assessment and blood hormonal levels. To better understand the neurobiology of aggression, aggressive patients that are not refractory will also be studied through neuroimaging and hormonal levels.
Trial Details
NCT Number NCT03452878
Lead Sponsor Hospital Sirio-Libanes
Conditions
(from sponsor)
Aggression
Related terms Aggression
Enrollment 4 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov